- SEK43.76m
- SEK37.92m
Brief: CombiGene: Rights Issue Subscribed With Over 80%
Brief: Combigene Q3 Pre-Tax Loss Narrows To SEK 3.5 Million
Brief: Combigene Signs Agreement With Cobra Biologics
Brief: CombiGene Makes Public Offer For Panion Animal Health
Brief: Combigene Approved For Listing On Nasdaq First North As Of Dec 19
Brief: Combigene July-Sept Operating Loss Sek 5.9 Million
Brief: Combigene Rights Issue Of SEK 31 Million Oversubscribed
Brief: Combigene April-June Pretax Loss Narrows To SEK 2.2 Mln
Brief: Combigene Announces Issue Of Units Of SEK 31 Million
Brief: Combigene: EU Finances Development Of Combigene's Technology With EUR 3.6 Mln
Brief: Combigene Q1 Operating Result Swings To Loss Of SEK 2 Million
Brief: CombiGene Raises SEK 2.3 Million In Rights Issue
Brief: CombiGene To Carry Out Rights Issue Of About SEK 10.2 Mln
Brief: CombiGene Signs Agreement With CGT Catapult
Brief: Combigene Q2 pretax loss widens to SEK 3.1 mln
Brief: CombiGene rights issue oversubscribed